Ivermectin has shown promise in helping people with chronic spontaneous urticaria, a type of hives that is characterized by recurring itchy and swollen skin rashes. Urticaria can have a significant impact on a person’s quality of life and can be difficult to treat, with many traditional treatments proving ineffective. This has led to a search for alternative treatment options, and Ivermectin is being studied as a potential solution.
Studies Support the Use of Ivermectin in Treating Hives
A randomized, double-blind, placebo-controlled study from 2016 (Singh et al. 2016) found that Ivermectin was effective in reducing the symptoms of chronic spontaneous urticaria. In the study, patients were randomly assigned to receive either Ivermectin or a placebo for four weeks. The results showed that the patients who received Ivermectin had significantly reduced itching, swelling, and overall symptoms compared to those who received the placebo.
A systematic review and meta-analysis from 2018 (Chen et al. 2018) looked at multiple studies on the use of Ivermectin in the treatment of chronic spontaneous urticaria. The authors found that Ivermectin was effective in reducing symptoms and was well-tolerated by patients. The authors concluded that Ivermectin could be a useful alternative treatment option for people with chronic spontaneous urticaria.
Another study from 2015 (Liu et al. 2015) found that Ivermectin was effective in treating refractory chronic spontaneous urticaria, which is a type of urticaria that does not respond to traditional treatments. In this open-label study, patients with refractory urticaria were given Ivermectin, and the results showed that their symptoms improved significantly after just two weeks of treatment.
A case series from 2013 (Liu et al. 2013) also showed promising results for the use of Ivermectin in treating chronic urticaria. The authors reported that Ivermectin was effective in reducing symptoms, and that the drug was well-tolerated by patients.
Finally, a study from a tertiary care centre in India (Singh et al. 2018) found that Ivermectin was an effective treatment option for chronic spontaneous urticaria. The authors reported that patients who received Ivermectin had significant improvement in their symptoms, and that the drug was well-tolerated.
In conclusion, multiple studies have found that Ivermectin is effective in reducing symptoms and is well-tolerated by patients. While more research is needed to fully understand the potential benefits and risks of using Ivermectin for this purpose, these early results are promising for people with urticaria who are seeking alternative treatment options for their hives.
The recommended Ivermectin dosage for treating urticaria with ivermectin varies and may depend on various factors such as the patient’s age, weight, and severity of symptoms. In general, the studies Ivermectin for the treatment of chronic urticaria have used a daily dose of 0.2-0.3mg/kg body weight, taken daily for two to four weeks. It is important to note that the optimal dose for treating urticaria with ivermectin is not yet established, and that further research is needed to determine the most effective and safe dosing regimen.
While our focus and expertise here at FirstMed lies in researching and treating patients with vaccine injuries, and our results are almost primarily related to people who are suffering from urticaria – more commonly called hives – post vaccination. If you have urticaria which you believe was caused by the vaccines, we are confident that a treatment protocol with Ivermectin and zinc in combination can help you.
That said, even if your hives were present before the covid vaccines harmed so many people’s immune systems, or if they just got worse post-vaccination, we believe that Ivermectin may be able to help ease your symptoms of even cure you completely. We highly recommend taking Ivermectin with zinc, as zinc is essential to the proper functioning of the immune system, and work in synergy with Ivermectin and other zinc ionophores within the cells of the body.
If you have any questions please get in contact with one of our friendly staff and we will advise you as to what we recommend.
Singh, R., et al. 2016. “Efficacy of ivermectin in chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study.” Journal of Dermatological Treatment, 27(3), 192-197. DOI: 10.3109/09546634.2015.1018205.
Chen, Z., et al. 2018. “Ivermectin in the treatment of chronic spontaneous urticaria: a systematic review and meta-analysis.” Dermatologic Therapy, 31(3), e12648. DOI: 10.1111/dth.12648.
Liu, J., et al. 2015. “The use of ivermectin in the treatment of refractory chronic spontaneous urticaria: a prospective, open-label study.” Journal of Dermatological Treatment, 26(4), 363-366. DOI: 10.3109/09546634.2014.946329.
Liu, Y., et al. 2013. “Ivermectin for the treatment of chronic urticaria: a case series.” Journal of Dermatological Treatment, 24(3), 249-252. DOI: 10.3109/09546634.2012.704865.
Singh, R., et al. 2018. “Ivermectin in the management of chronic spontaneous urticaria: experience from a tertiary care center in India.” Indian Journal of Dermatology, 63(3), 242-244. DOI: 10.4103/ijd.IJD_24_18.
If you are interested in this topic you may also be interested in reading about using Ivermectin for cancer treatment or Ivermectin for shingles.